iPath Return on Disability ETN
RODI
RODI was delisted on the 20th of December, 2022.
1 hedge funds and large institutions have $0 invested in iPath Return on Disability ETN in 2015 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital invested
Capital invested by funds: $18M → $0 (-$18M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$18M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Barclays
London,
United Kingdom
| – | -$18M | -500,100 | Closed |
|
RODI Hedge Fund Activity: Q2 2015 in Review
1 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in iPath Return on Disability ETN (RODI) for Q2 2015, worth a combined $0 — down 100% from $18M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of RODI and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Barclays, exiting entirely with an estimated $18M sold.
- 1 institutional investor held iPath Return on Disability ETN (RODI) as of Q2 2015, down from 2 in Q1 2015.
- Funds reported $0 of iPath Return on Disability ETN stock for Q2 2015, down 100% quarter-over-quarter.
- 0 funds opened new iPath Return on Disability ETN positions in Q2 2015 and 1 closed out, a net change of -1 holder.
- The largest iPath Return on Disability ETN seller in Q2 2015 was Barclays, an estimated $18M sold.
Based on aggregated 13F filings for Q2 2015.